Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Feb;7(1):100389.
doi: 10.1016/j.esmoop.2022.100389. Epub 2022 Feb 2.

Bile cell‑free DNA: a game changer for management of biliary tract cancer?

Affiliations
Comment

Bile cell‑free DNA: a game changer for management of biliary tract cancer?

A Rizzo et al. ESMO Open. 2022 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors have declared no conflicts of interest.

Comment on

References

    1. Abou-Alfa G.K., Sahai V., Hollebecque A., Vaccaro G., Melisi D., Al-Rajabi R., et al. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol. 2020;21(5):671–684. - PMC - PubMed
    1. Banales J.M., Marin J.J.G., Lamarca A., Rodrigues P.M., Khan S.A., Roberts L.R., et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557–588. - PMC - PubMed
    1. Gou Q., Zhang C.Z., Sun Z.H., Wu L.G., Chen Y., Mo Z.Q., et al. Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer. ESMO Open. 2021;6(6):100275. - PMC - PubMed
    1. Jaiswal S., Fontanillas P., Flannick J., Manning A., Grauman P.V., Mar B.G., et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488–2498. - PMC - PubMed
    1. Driescher C., Fuchs K., Haeberle L., Goering W., Frohn L., Opitz F.V., et al. Bile-based cell-free DNA analysis is a reliable diagnostic tool in pancreatobiliary cancer. Cancers (Basel) 2020;13(1):39. - PMC - PubMed

Substances